The safety and efficacy of minimal dose of mitomycin C in trabeculectomy
Aim: To evaluate the safety and efficacy of minimal concentration and exposure time of mitomycin C (MMC) (0.1 mg/mL for 2 min) as an adjunct to trabeculectomy and to evaluate the complications of minimal dose of MMC in trabeculectomy. Background: Glaucoma ranks second as the most common cause of bli...
Main Authors: | Rekha Bellulli Kotrappa, Arvind Y Yakkundi, Bhagyajyothi Balappa Khangavi, Anju Meena, Dhara Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of the Scientific Society |
Subjects: | |
Online Access: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2016;volume=43;issue=3;spage=135;epage=139;aulast=Kotrappa |
Similar Items
-
Our results of large area mitomycin C application trabeculectomy in cases with advanced glaucoma
by: Mutlu Cihan Dağlıoğlu, et al.
Published: (2013-12-01) -
Revision of trabeculectomy filtering blebs with mitomycin C: Long term results
by: Maria Tulidowicz-Bielak, et al.
Published: (2016-01-01) -
Trabeculectomy with subconjunctival collagen implant in Indian eyes: Long-term results
by: Kirti Singh, et al.
Published: (2018-01-01) -
Effect of mitomycin-c-assisted sutureless trabeculectomy on keratometry and axial length
by: Anant Sharma, et al.
Published: (2017-01-01) -
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C
by: Sharmila Rajendrababu, et al.
Published: (2019-01-01)